Ignite Creation Date:
2024-05-05 @ 11:07 PM
Last Modification Date:
2024-10-26 @ 10:28 AM
Study NCT ID:
NCT01255527
Status:
UNKNOWN
Last Update Posted:
2013-06-04
First Post:
2010-12-06
Brief Title:
Evaluating the Efficacy and Safety of the Lower Dose of Bortezomib Plus Busulfan and Melphalan as a Conditioning Regimen in Patients With Multiple Myeloma Undergoing Autologous Peripheral Blood Stem Cell Transplantation- KMM103 Study
Sponsor:
Yonsei University
Organization:
Yonsei University
Organization Data
Organization:
Yonsei University
Class:
OTHER
Study ID:
4-2010-0482
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Yonsei University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None